NASDAQ:CLRB

Cellectar Biosciences - CLRB Earnings Date, Estimates & Call Transcripts

$5.85

-0.02 (-0.34%)

(As of 08/11/2022 12:00 AM ET)

Add

Compare

Today's Range: $5.63
▼
$5.90
50-Day Range: $3.57
▼
$6.23
52-Week Range: $3.37
▼
$10.90

Volume: 30,005 shs
Average Volume: 20,922 shs
Market Capitalization: $35.74 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $21.25

Upcoming Earnings Date: Nov. 14Estimated
Actual EPS (May. 10): -$1.00 Beat By $0.10
Consensus EPS (May. 10): -$1.10
Last Year's Q2 EPS (5/9/2021): -$1.30

Read Call Transcript

Listen to Call

Earnings Per Share Revenue

CLRB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CLRB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Cellectar Biosciences Analyst Forecasts

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2022	1	($0.11)	($0.11)	($0.11)
Q2 2022	1	($0.11)	($0.11)	($0.11)
Q3 2022	1	($1.25)	($1.25)	($1.25)
Q4 2022	1	($1.12)	($1.12)	($1.12)
FY 2022	4	($2.59)	($2.59)	($2.59)
Q1 2023	1	($0.60)	($0.60)	($0.60)
Q2 2023	1	($0.62)	($0.62)	($0.62)
Q3 2023	1	($0.63)	($0.63)	($0.63)
Q4 2023	1	($0.21)	($0.21)	($0.21)
FY 2023	4	($2.06)	($2.06)	($2.06)

CLRB Earnings Date and Information

Cellectar Biosciences last released its quarterly earnings results on May 10th, 2022. The biopharmaceutical company reported ($1.00) earnings per share for the quarter, topping the consensus estimate of ($1.10) by $0.10. Cellectar Biosciences has generated ($4.22) earnings per share over the last year (($4.22) diluted earnings per share). Earnings for Cellectar Biosciences are expected to grow in the coming year, from ($4.28) to ($3.39) per share. Cellectar Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 14th, 2022 based off prior year's report dates.

Cellectar Biosciences Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Actual Revenue
11/14/2022 (Estimated)
5/10/2022	Q1 2022	($1.10)	($1.00)	+$0.10	($0.10)
3/21/2022	Q4 2021	($1.00)	($1.00)		($0.10)
11/7/2021	9/30/2021	($1.10)	($1.00)	+$0.10	($0.10)
8/8/2021	6/30/2021	($1.10)	($1.10)		($0.11)
5/9/2021	3/31/2021	($1.00)	($1.30)	($0.30)	($0.13)
3/1/2021	12/31/2020	($1.50)	($0.70)	+$0.80	($0.07)
11/14/2020	9/30/2020	($2.00)	($1.50)	+$0.50	($0.15)
8/10/2020	6/30/2020	($2.80)	($2.60)	+$0.20	($0.26)
5/7/2020	3/31/2020	($3.50)	($4.20)	($0.70)	($0.42)
3/9/2020	12/31/2019	($3.70)	($3.30)	+$0.40	($0.33)

11/12/2019	Q3 2019	($3.80)	($4.20)	($0.40)	($0.42)
8/12/2019	Q2 2019	($6.95)	($4.60)	+$2.35	($0.46)
5/6/2019	Q1 2019	($7.40)	($7.60)	($0.20)	($0.76)
11/13/2018	Q3 2018	($8.30)	($16.50)	($8.20)	($1.65)
8/10/2018	Q2 2018	($21.00)	($16.90)	+$4.10	($1.69)
5/11/2018	Q1 2018	($20.00)	($21.00)	($1.00)	($0.21)
3/21/2018	Q4 2017	($23.00)	($34.00)	($11.00)	($34.00)
11/9/2017	Q3 2017	($25.00)	($26.00)	($1.00)	($0.26)
8/14/2017	Q2 2017	($24.00)	($23.00)	+$1.00	($0.23)
5/11/2017	Q1 2017	($23.00)	($24.00)	($1.00)	($0.24)
3/15/2017	Q4 2016	($23.00)	($35.00)	($12.00)	($0.36)
11/10/2016	Q3 2016	($20.00)	($43.00)	($23.00)	($0.43)
8/11/2016	Q2 2016	($40.00)	($49.00)	($9.00)	($0.49)
5/12/2016	Q1 2016		$91.00	+$91.00	$0.91
11/12/2015	Q315		($25.00)	($25.00)	($0.25)
8/12/2015	Q215		($30.00)	($30.00)	($0.30)
5/21/2015	Q115		($30.00)	($30.00)	($0.30)
3/24/2015	Q4 2014		($220.00)	($220.00)	($2.20)
11/11/2014	Q3 2014		($100.00)	($100.00)	($1.00)
8/20/2014	Q2 2014		($660.00)	($660.00)	($5.90)
5/14/2014	Q1 2014		($1,000.00)	($1,000.00)	($10.00)
3/25/2014	Q4 2013	($800.00)	($1,000.00)	($200.00)	($6.00)
11/6/2013	Q3 2013	($1,000.00)	($1,400.00)	($400.00)	$2.00	$92.67 million
8/12/2013	Q2 2013	($1,000.00)	($1,000.00)		($12.00)
5/15/2013	Q1 2013	($800.00)	($1,200.00)	($400.00)	($10.00)
5/4/2012	Q1 2012	($1,200.00)	($1,180.00)	+$20.00	($11.60)
3/9/2012	Q4 2011		($1,200.00)	($1,200.00)	($12.00)
11/7/2011	Q3 2011		($1,420.00)	($1,420.00)	($14.20)
8/18/2011	Q2 2011		($2,020.00)	($2,020.00)	($20.20)

Cellectar Biosciences Earnings - Frequently Asked Questions

When is Cellectar Biosciences's earnings date?: Cellectar Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 14th, 2022 based off last year's report dates. Learn more on CLRB's earnings history.
Did Cellectar Biosciences beat their earnings estimates last quarter?: In the previous quarter, Cellectar Biosciences (NASDAQ:CLRB) reported ($1.00) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.10) by $0.10. Learn more on analysts' earnings estimate vs. CLRB's actual earnings.
How can I listen to Cellectar Biosciences's earnings conference call?: The conference call for Cellectar Biosciences's latest earnings report can be listened to online. Listen to Conference Call
How can I read Cellectar Biosciences's conference call transcript?: The conference call transcript for Cellectar Biosciences's latest earnings report can be read online. Read Transcript

How much profit does Cellectar Biosciences generate each year?: Cellectar Biosciences (NASDAQ:CLRB) has a recorded net income of -$24.12 million. CLRB has generated -$4.22 earnings per share over the last four quarters.
What is Cellectar Biosciences's EPS forecast for next year?: Cellectar Biosciences's earnings are expected to grow from ($4.28) per share to ($3.39) per share in the next year.

More Earnings Resources from MarketBeat

Earnings Tools:

Earnings By Country:

Latest Articles:

Upcoming Earnings:

BHP Group (8/16/2022)
Walmart (8/16/2022)
Home Depot (8/16/2022)
Cisco Systems (8/17/2022)
Analog Devices (8/17/2022)
Synopsys (8/17/2022)
TJX Companies (8/17/2022)
Target (8/17/2022)
Lowe's Companies (8/17/2022)
NetEase (8/18/2022)

This page (NASDAQ:CLRB) was last updated on 8/11/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources